UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 3, 2015
_________________
22nd
Century Group, Inc.
(Exact
Name of Registrant as Specified in Charter)
Nevada |
001-36338 |
98-0468420 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer
Identification No.) |
|
|
|
9530 Main Street
Clarence, New York
(Address of Principal Executive Office) |
14031
(Zip Code) |
Registrant’s telephone number, including
area code: (716) 270-1523 |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 3, 2015, 22nd
Century Group, Inc. (the “Company”) appointed Henry Sicignano III, age 47, to the position of Chief Executive Officer.
Mr. Sicignano will continue to serve as the Company’s President and will remain on the Board of Directors. The information
required to be disclosed pursuant to Items 401(b), (d), (e) and Item 404(a) of Regulation S-K is set forth in the Company’s
annual meeting proxy statement filed with the Securities and Exchange Commission on March 4, 2014 and is incorporated herein by
reference.
Item
7.01 Regulation FD Disclosure.
On March 3, 2015, the
Company issued a press release announcing the appointment of Henry Sicignano, III as Chief Executive Officer. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in
this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”), or otherwise subject to the liabilities of Section 18, nor shall it be deemed incorporated by reference in any of
the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent, if any, expressly
set forth by specific reference in such filing.
Item
9.01(d) Financial Statements and Exhibits.
Exhibit 99.1 Press Release issued
by 22nd Century Group, Inc.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
22nd Century Group, Inc. |
|
|
|
|
|
|
|
|
/s/ Henry Sicignano, III |
|
Date March 3, 2015 |
Henry Sicignano, III
President and Chief Executive Officer |
|
Exhibit 99.1
22nd Century Group Names Henry Sicignano
III Chief Executive Officer
March 03, 2015 12:46 PM Eastern Standard Time
CLARENCE, N.Y. - 22nd Century Group, Inc. (NYSE MKT:
XXII) announced today that Henry Sicignano III has been named to the position of Chief Executive Officer. Mr. Sicignano
will continue to serve as the Company’s President and will remain on the Board of Directors.
“The Board of Directors has had the opportunity to work
directly with Henry over the past few months and is convinced that there is no better person to lead the company forward,”
said James W. Cornell, Chairman of the Board of Directors. “Henry is a proven leader with outstanding business development
skills, strategic vision and the ability to bring people together. His vision for how 22nd Century will monetize the Company’s
proprietary technologies is exactly what 22nd Century needs at this exciting stage in the Company’s growth.”
Since joining the Company as President in 2010, Mr. Sicignano
has spearheaded major initiatives across a range of business areas, recently establishing a strategic partnership with Smoker Friendly
International, the nation’s largest dealer network of cigarette stores, and securing contract manufacturing and distribution
agreements to launch the Company’s MAGIC® brand of cigarettes in Europe. Going forward, Mr. Sicignano has
defined 22nd Century’s top priorities as: establishing multi-year international sales contracts for the Company’s proprietary
tobacco products (with immediate focus on Asia); submitting to the FDA a Modified Risk Application for the Company’s Brand
A very low nicotine cigarettes; and identifying a joint venture partner to fund Phase III clinical trials for X-22, the
Company’s smoking cessation aid in development.
“22nd Century is in the rare position of having a virtual
monopoly around the nicotine biosynthetic pathway in the tobacco plant; I am honored and tremendously excited to have been chosen
to lead the Company as we begin to commercialize our extraordinary IP portfolio,” Mr. Sicignano said. “As the tobacco
industry begins a true paradigm shift toward the development and commercialization of reduced-risk tobacco products, 22nd Century
is uniquely positioned to become a key player in both the smoking harm reduction and the smoking cessation markets. A key part
of my job will be to seize these opportunities by focusing our management team and the Company’s business development investments
on our technology’s most important commercial applications.”
For additional information about 22nd Century Group, please
visit: www.xxiicentury.com
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company whose
proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine)
in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. The Company’s technology
also allows the levels of cannabinoids to be decreased or increased in the cannabis plant. 22nd Century owns or exclusively controls
128 issued patents plus an additional 52 pending patent applications; the patents owned by us or exclusively licensed to us include
patents issued in 96 countries. Goodrich Tobacco is focused on commercial tobacco products and potentially less harmful cigarettes.
Botanical Genetics is focused on novel cannabis plant varieties and on cannabis-based products. Hercules Pharmaceuticals is focused
on X-22, a prescription smoking cessation aid in development.
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking information, including all statements that are not statements of historical fact
regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect
to the contents of this press release. The words “may,” “would,” “will,”
“expect,” “estimate,” “anticipate,” “believe,” “intend” and
similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future
results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which
speak only as of the date that they were made. These cautionary statements should be considered with any written or oral
forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities
laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to
reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should
carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended
December 31, 2014, filed on February 5, 2015, including the section entitled “Risk Factors,” and our other
reports filed with the U.S Securities and Exchange Commission which attempt to advise interested parties of the risks and
factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks
or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially
from those expected or projected.
Redington, Inc.
Tom Redington
203-222-7399
http://www.businesswire.com/news/home/20150303006412/en
22nd Century (AMEX:XXII)
Historical Stock Chart
From Mar 2024 to Apr 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2023 to Apr 2024